V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003666 | 280002720 | 1.79 | 58.5 | Neo-adjuvant (N) | 2016-07-30 | 2016-08-16 | Doxorubicin + Ifosfamide | 02 | N | 280025946 | DOXORUBICIN + IFOSFAMIDE |
| 280003667 | 280002720 | 1.66 | 88.8 | Neo-adjuvant (N) | 2015-01-22 | 2015-01-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025946 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003668 | 280002721 | 1.6 | 63.4 | Curative (C) | 2017-07-12 | 2017-08-04 | CISPLATIN + FLUOROURACIL | 02 | N | 280025954 | CISPLATIN + FLUOROURACIL |
| 280003669 | 280002722 | 1.73 | 71.1 | Neo-adjuvant (N) | null | 2014-02-03 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025956 | CISPLATIN + FLUOROURACIL |
| 280003670 | 280002723 | 1.67 | 91.9 | Curative (C) | 2014-07-19 | 2014-08-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025958 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003671 | 280002724 | 1.73 | 87.4 | Curative (C) | 2015-07-13 | 2015-07-26 | Cetuximab + Radiotherapy Load | N | Y | 280025960 | CETUXIMAB + RT |
| 280003672 | 280002725 | 1.63 | 105.8 | Neo-adjuvant (N) | 2016-03-20 | 2016-03-21 | Doxorubicin + Ifosfamide | 02 | N | 280025961 | DOXORUBICIN + IFOSFAMIDE |
| 280003673 | 280002726 | 1.74 | 75.1 | Not known (9) | null | 2015-06-23 | CISPLATIN + FLUOROURACIL | N | N | 280025962 | CISPLATIN + FLUOROURACIL |
| 280003674 | 280002727 | 1.6 | 76.6 | Curative (C) | 2013-06-28 | 2013-07-09 | CETUXIMAB + RT | N | Y | 280025963 | CETUXIMAB + RT |
| 280003675 | 280002727 | null | 63.4 | Neo-adjuvant (N) | 2017-09-15 | 2017-09-15 | Doxorubicin + Ifosfamide | 02 | N | 280025963 | DOXORUBICIN + IFOSFAMIDE |
| 280003676 | 280002728 | null | 50.5 | Neo-adjuvant (N) | null | 2017-04-06 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025965 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003677 | 280002729 | 1.8 | 88.8 | Neo-adjuvant (N) | 2014-06-13 | 2014-06-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025966 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003678 | 280002730 | null | 81 | Curative (C) | 2017-06-24 | 2017-06-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025968 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003679 | 280002731 | 165 | 75.2 | Adjuvant (A) | 2013-06-22 | 2013-07-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025970 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003680 | 280002732 | 1.66 | null | Curative (C) | null | 2017-01-27 | Doxorubicin + Ifosfamide | null | null | 280025971 | DOXORUBICIN + IFOSFAMIDE |
| 280003681 | 280002733 | null | null | Curative (C) | 2017-09-17 | 2017-09-28 | CISPLATIN + FLUOROURACIL | N | N | 280025972 | CISPLATIN + FLUOROURACIL |
| 280003682 | 280002734 | 1.8 | 98 | Palliative (P) | 2016-02-01 | 2016-02-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025973 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003683 | 280002734 | 1.73 | 71 | null | 2017-02-06 | 2017-02-13 | CETUXIMAB + RT | 02 | null | 280025973 | CETUXIMAB + RT |
| 280003684 | 280002735 | 1.79 | 51.5 | Curative (C) | 2016-10-23 | 2016-11-05 | CETUXIMAB + RT | 2 | N | 280025976 | CETUXIMAB + RT |
| 280003685 | 280002736 | 1.75 | 106 | Palliative (P) | null | 2017-12-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025978 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003686 | 280002737 | 1.76 | null | Curative (C) | 2017-04-30 | 2017-05-06 | Cisplatin +Fluorouracil (3 wk) | N | null | 280025980 | CISPLATIN + FLUOROURACIL |
| 280003687 | 280002737 | 1.9 | 87 | Neo-adjuvant (N) | 2015-12-26 | 2016-01-17 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025980 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003688 | 280002738 | 1.7 | 79.6 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-02 | Doxorubicin + Ifosfamide | 02 | N | 280025985 | DOXORUBICIN + IFOSFAMIDE |
| 280003689 | 280002739 | 1.62 | null | Palliative (P) | 2014-12-08 | 2014-12-30 | Doxorubicin + Ifosfamide | 02 | N | 280025986 | DOXORUBICIN + IFOSFAMIDE |
| 280003690 | 280002740 | 1.54 | 90.8 | Neo-adjuvant (N) | 2013-02-01 | 2013-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025987 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003691 | 280002741 | 1.57 | 60 | Curative (C) | 2014-03-14 | 2014-03-28 | CETUXIMAB + RT | N | N | 280025988 | CETUXIMAB + RT |
| 280003692 | 280002742 | 1.51 | 81.2 | Palliative (P) | 2014-04-21 | 2014-04-21 | CISPLATIN + FLUOROURACIL | 01 | null | 280025989 | CISPLATIN + FLUOROURACIL |
| 280003693 | 280002743 | null | 122.8 | Curative (C) | null | 2016-08-15 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025990 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003694 | 280002744 | 1.67 | 74 | Curative (C) | 2015-11-18 | 2015-12-03 | CETUXIMAB + RT | 2 | Y | 280025991 | CETUXIMAB + RT |
| 280003695 | 280002745 | null | null | Palliative (P) | 2014-05-15 | 2014-05-23 | CETUXIMAB + RT | N | Y | 280025992 | CETUXIMAB + RT |
| 280003696 | 280002746 | 1.79 | null | Neo-adjuvant (N) | 2017-09-30 | 2017-10-08 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025993 | CISPLATIN + FLUOROURACIL |
| 280003697 | 280002747 | 0.76 | 78.2 | Neo-adjuvant (N) | 2017-05-13 | 2017-06-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025996 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003698 | 280002748 | 1.81 | 69.2 | Disease modification (D) | null | 2016-06-28 | Doxorubicin + Ifosfamide | N | N | 280025997 | DOXORUBICIN + IFOSFAMIDE |
| 280003699 | 280007352 | 1.74 | 117.4 | Curative (C) | 2013-09-23 | 2013-09-28 | Cetuximab + Radiotherapy Load | N | N | 280025998 | CETUXIMAB + RT |
| 280003700 | 280007352 | 1.85 | null | Neo-adjuvant (N) | 2013-04-17 | 2013-04-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025998 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003701 | 280002749 | 1.77 | 88.7 | Neo-adjuvant (N) | 2014-12-13 | 2014-12-14 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280026003 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003702 | 280007353 | 1.84 | 74.6 | Curative (C) | 2014-02-18 | 2014-03-06 | CISPLATIN + FLUOROURACIL | N | N | 280026004 | CISPLATIN + FLUOROURACIL |
| 280003703 | 280002750 | 1.74 | 93 | Neo-adjuvant (N) | 2017-08-09 | 2017-09-05 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026005 | CISPLATIN + FLUOROURACIL |
| 280003704 | 280002751 | 1.65 | 73.7 | Curative (C) | 2013-06-27 | 2013-06-29 | CETUXIMAB + RT | N | N | 280026006 | CETUXIMAB + RT |
| 280003705 | 280002751 | 1.74 | 66 | Curative (C) | 2017-01-22 | 2017-02-20 | CISPLATIN + FLUOROURACIL | 02 | N | 280026006 | CISPLATIN + FLUOROURACIL |
| 280003706 | 280002752 | 1.76 | 96.8 | Neo-adjuvant (N) | 2014-01-08 | 2016-06-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026011 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003707 | 280002753 | 1.58 | 118 | Curative (C) | 2016-08-22 | 2016-09-06 | Cetuximab + Radiotherapy Load | N | Y | 280026014 | CETUXIMAB + RT |
| 280003708 | 280002754 | 1.61 | null | Curative (C) | null | 2017-09-01 | CETUXIMAB + RT | null | null | 280026015 | CETUXIMAB + RT |
| 280003709 | 280002754 | null | 62.6 | Neo-adjuvant (N) | 2013-07-16 | 2013-07-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026015 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003710 | 280002755 | 2 | 70.4 | Neo-adjuvant (N) | 2017-08-06 | 2017-08-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026017 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003711 | 280002755 | 1.8 | 120 | Neo-adjuvant (N) | 2015-09-05 | 2015-09-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026017 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003712 | 280002755 | 1.93 | 52 | Neo-adjuvant (N) | 2016-06-21 | 2016-06-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280026017 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003713 | 280002755 | 1.75 | 82.2 | null | 2013-11-16 | 2013-11-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026017 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003714 | 280002756 | 1.47 | null | Neo-adjuvant (N) | null | 2013-08-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026025 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003715 | 280002757 | 1.75 | 148 | Not known (9) | 2015-09-02 | 2015-09-05 | Cetuximab + Radiotherapy Load | N | N | 280026026 | CETUXIMAB + RT |